SurModics, Inc.

3mon ago, source: CNN

Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests ...

SurModics earnings: here's what Wall Street expects

2h ago, source:

SurModics will release earnings for the most recent quarter on May 1.Wall Street analysts expect SurModics will report losses per share of ...

Surmodics (NASDAQ: SRDX)

14d ago, source: The Motley Fool

Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays.

Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1

11d ago, source:

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare ...

New Strong Buy Stocks for April 9th

21d ago, source: Yahoo Finance

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Surmodics, Inc. SRDX: This medical device coating technology provider has seen the Zacks Consensus Estimate for its current ...

Surmodics to Participate in Upcoming Investor Conferences in March and April

23d ago, source: ADVFN

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that management will participate in the ...

Surmodics, Inc.

11d ago, source: U.S. News & World Report

For most investors, the best investment strategy is to buy good stocks and hold them for the long run.

Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1

11d ago, source: Morningstar

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 ...

Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1

11d ago, source: Stockhouse

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial ...

Surmodics Inc.

10mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...